N/A
Completed N=1,665
Randomized Trial of Telemedicine for Diabetes Care
Source: ClinicalTrials.gov NCT00271739 ↗Enrolled (actual)
1,665
Serious AEs
0.0%
Results posted
Aug 2011
Primary outcomePrimary: Hemoglobin A1c Levels — 7.09; 7.38 A1c percentage
Summary
The IDEATel study is a multicenter randomized controlled trial to evaluate the efficacy, acceptability, and cost-effectiveness of telemedicine case management to provide diabetes care to elderly Medicare beneficiaries residing in medically underserved areas of New York State.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Hemoglobin A1c Levels |
7.09; 7.38 | — |
| PRIMARY Blood Pressure Levels |
135.83; 140.15 | — |
| PRIMARY Serum Lipids Levels; Low-density Lipoprotein (LDL)-Cholesterol |
91.13; 94.97 | — |
Eligibility Criteria
Inclusion Criteria
- Age 55 years or greater
- Being a current Medicare beneficiary (verified by the Centers for Medicare and Medicaid Services)
- Having diabetes mellitus as defined by a physician's diagnosis and being on treatment with diet, an oral hypoglycemic agent, or insulin
- Residence in a federally designated medically underserved area (either of two federal designations, Medically Underserved Area [MUA] or Health Manpower Shortage Area [HPSA]) in New York Sate
- Fluency in either English or Spanish
Exclusion Criteria
- Moderate or severe cognitive, visual, or physical impairment
- The presence of severe co-morbid disease.
Data sourced from ClinicalTrials.gov (NCT00271739). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.